PTEN and acute myeloid leukemia: SALL1 silencing decreased human primary AML cell proliferation, resulted in low AML engraftment into NSG mice, and correlated with the upregulation of PTEN and the downregulation of mTOR, β-catenin, and NF-қB expression.